🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The main objective is to determine whether immune responses to Tdap (GlaxoS...
Status
Completed
Location
Birmingham Pediatrics, 806 Saint Vincent's Drive, Suite 615
Start Date
2011-09
Trial ID
NCT01424644
The purpose of this study is to look at the safety and immunogenicity of a ...
Status
Completed
Location
Duke University Medical Center - Duke Perinatal Clinic
Start Date
2009-01
Trial ID
NCT00707148
Treatments Being Tested
This study will evaluate the safety and immune response of the Novartis Men...
Status
Completed
Location
San Jose, Costa Rica
Start Date
2007-07
Trial ID
NCT00518180
Objectives: To provide safety data on revaccination with ADACEL® vaccine. ...
Status
Completed
Location
Multiple Locations
Start Date
2006-08
Trial ID
NCT00347958
Treatments Being Tested
The aim of the study is to assess the immunogenicity and safety profile of ...
Status
Completed
Location
Multiple Locations
Start Date
2013-11
Trial ID
NCT01993173
The goal of this clinical trial is to investigate the safety and tetanus an...
Status
Completed
Location
ABO Plasma
Start Date
2023-05-05
Trial ID
NCT05662852
Treatments Being Tested
Recently, the Tdap (tetanus toxoid, reduced diphtheria toxoid and acellular...
Status
Unknown
Location
Mindful Diagnostics and Therapeutics
Start Date
2023-05-01
Trial ID
NCT05183516
Treatments Being Tested
Primary Objectives : * To describe the long-term humoral immune responses ...
Status
Completed
Location
Investigational Site Number : 7100001
Start Date
2021-01-27
Trial ID
NCT04300192
Currently, there is no 5-component acellular pertussis vaccine licensed for...
Status
Completed
Location
Multiple Locations
Start Date
2007-04
Trial ID
NCT00467519
This phase II trial compares the effect of folate receptor alpha dendritic ...
Status
Recruiting
Location
Mayo Clinic in Arizona
Start Date
2024-11-08
Trial ID
NCT06639074
Treatments Being Tested